Search Results
81 items found for "Lipeng Shang"
- 📰 GPCR Weekly News, March 6 to 12, 2023
de l'Innovation Technologique (Technological Innovation Award) Sosei Heptares Receives Approval for Change
- 📰 GPCR Weekly News, September 25 to October 1, 2023
Lefkowitz's Career at Duke October 3, 2023, | FREE Seminar: Changing paradigm on Therapeutics targeting
- 📰 GPCR Weekly News, September 18 to 24, 2023
Lefkowitz's Career at Duke October 3, 2023, | FREE Seminar: Changing paradigm on Therapeutics targeting
- 📰 GPCR Weekly News, September 11 to 17, 2023
Lefkowitz's Career at Duke October 3, 2023, | FREE Seminar: Changing paradigm on Therapeutics targeting
- 📰 GPCR Weekly News, August 28 to September 3, 2023
Drug Targets: Allosteric Function and Biased Signaling" at the DOT NEW October 3, 2023 | FREE Seminar: Changing
- 📰 GPCR Weekly News, February 5 to 11, 2024
cAMP signaling in the Hedgehog pathway Unraveling the Interplay of Extracellular Domain Conformational Changes
- 📰 Breaking Down the Latest GPCR Discoveries: a Weekly Update (Nov 27-Dec 3, 2023)
Allostery of G-Protein-Coupled Receptors Industry News Sosei Heptares to take back GPCR agonist after GSK changes
- 📰 GPCR Weekly News, April 24 to 30, 2023
WNT stimulation induces dynamic conformational changes in the Frizzled-Dishevelled interaction.
- 📰 GPCR Weekly News, November 13 to 19, 2023
cannabidiol, on the cannabinoid CB2 receptor GPCRs in Cardiology, Endocrinology, and Taste Transcriptomic changes
- 📰 GPCR Weekly News, March 13 to 19, 2023
GPCRs in Neuroscience Physiological Condition-Dependent Changes in Ciliary GPCR Localization in the Brain
- 📰 GPCR Weekly News, February 12 to 18, 2024
multifaceted role of the CXC chemokines and receptors signaling axes in ALS pathophysiology Common changes
- 📰 GPCR Weekly News
Quantification of changes in human islet G protein-coupled receptor mRNA expression in obesity.
- Structural landscape of the Chemokine Receptor system
Conformational changes between inactive and active states are facilitated by a "microswitch network" inverse agonist (maraviroc) (Tan, Zhu et al. 2013, Zheng, Han et al. 2017, Isaikina, Tsai et al. 2021, Zhang , exhibits bias toward G-protein signaling, which has been structurally related to a conformational change
- Nanobodies: New Dimensions in GPCR Signaling Research
They have also been used as biosensors to monitor conformational changes of GPCRs in living cells.
- Regulators of G-protein signaling: essential players in GPCR signaling
Upon activation, GPCRs have conformational changes that allow the coupling and subsequent activation
- Transformative GPCR Insights: Unleash New Horizons in Science | Sep 9 - 15, 2024
announced the winners of its Transforming Cancer Therapeutics grant, which focuses on developing life-changing
- Targeting Intracellular Allosteric Sites in GPCRs
or more of the following pharmacological characteristics: 1) affinity modulation where the resulting change
- 📰 GPCR Weekly News, March 25 to March 31, 2024
Sosei Heptares Confirms Re-election of its Board and Executive Management Team and the Approval of Change
- ShouTi Introduces Basecamp Bio as a Wholly Owned Subsidiary to Expand Pipeline and Partnerships
March 2022 "February 17, 2022 08:00 AM Eastern Standard Time SAN FRANCISCO & SHANGHAI- ShouTi Inc.,
- Overview of adhesion GPCRs self-activation
structural perspective, the -4 position of αH5 was key for the selectivity of G-protein coupling, since the change , Z., Liu, C., Li, X., Zhu, X., Wang, N., Xu, Z., Xia, R., Liang, J., Duan, Y., Yin, H., Xiong, Y., Zhang
- Feeder or trigger – CCR2 as a scavenger and regulator of cell migration
2000), becoming incapable of promoting cell migration, a phenomenon which is likely to be mediated by changes
- Glyco-sulfo hotspots in the chemokine receptor system
extracellular loops and transmembrane domains of the receptor (CRS2), which will trigger conformational changes
- An overview of the compartmentalized GPCR Signaling: Relevance and Implications
the lipid composition of intracellular membranes may influence GPCR dynamics and signaling outcomes, changing Z., Wilderman, A., Katakia, T., McCann, T., Yokouchi, H., Zhang, L., Corriden, R., Liu, D., Feigin, M
- Artificial intelligence – faster, smarter, cheaper GPCR drug discovery
, such as ligand binding sites (orthosteric, allosteric), activation mechanisms, and conformational changes
- Unlocking the Therapeutic Potential of Previously Undruggable GPCRs
However, the receptors that these medicines target have been described as the ‘low-hanging’ fruit, and These interactions induce local conformational changes which are amplified and transmitted to the intracellular